SCHEMBL7220757

SCHEMBL7220757

Cn1cc(C(=O)O)c(=O)c2c3ccc(N4CCCCC4)c(F)c3ncc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 1/20 0.41
HSP90AA1 P07900 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
LMNA P02545 4/20 0.37
CASP1 P29466 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
DRD3 P35462 1/20 0.36
HPGD P15428 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HRH3 Q9Y5N1 1/20 0.34
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
PIK3CG P48736 1/20 0.33
BRD4 O60885 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
CYP2J2 P51589 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219802 0.99 ALDH1A1 (0.41) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7226972 0.89 LMNA (0.35) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7227171 0.89 ALDH1A1 (0.34) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7220091 0.89 LMNA (0.34) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7220276 0.89 LMNA (0.46) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7227605 0.87 LMNA (0.48) ALDH1A1KDM4ELMNACASP1MEN1
SCHEMBL7220314 0.87 KCNH2 (0.34) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7220770 0.86 LMNA (0.48) ALDH1A1KDM4ELMNACASP1MEN1
SCHEMBL7227944 0.86 RPS6KB1 (0.44) ALDH1A1KDM4EPOLBHSP90AA1RXFP1
SCHEMBL7221681 0.86 HPGD (0.38) ALDH1A1KDM4EPOLBHSP90AA1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566362-B2 Use as topical antibiotics AVENTIS PHARMA S.A. (FR) 2003-05-20 US disclosed
US-20020137741-A1 Benzo[f]naphthyridine derivatives, their preparation and compositions containing them AVENTIS PHARMA S.A. (FR) 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137741-A1 Benzo[f]naphthyridine derivatives, their preparation and compositions containing them KCNQ2, KCNQ1, KCNQ4 ALDH1A1 719/4885KDM4E 1398/4885POLB 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.